Alpha Cognition Inc., a Canadian company operating within the Health Care sector, has recently been the subject of market attention due to its performance on the Canadian National Stock Exchange. As of November 10, 2026, the company’s close price stood at USD 8.62. This figure is notably above its 52-week low of USD 4.5, recorded on February 4, 2026, yet below its 52-week high of USD 10.14, achieved on August 23, 2026.
The company’s market capitalization is currently valued at USD 190,120,000, reflecting its standing and influence within the health care sector. Alpha Cognition Inc. specializes in cognitive health solutions, focusing on innovative approaches to enhance cognitive function and address cognitive impairments.
The recent trading activity indicates a period of volatility for Alpha Cognition Inc., with its stock price experiencing significant fluctuations over the past year. Investors and analysts are closely monitoring the company’s strategic initiatives and market developments to gauge future performance.
Alpha Cognition Inc.’s presence on the Canadian National Stock Exchange underscores its commitment to growth and expansion within the health care industry. The company continues to invest in research and development, aiming to advance its portfolio of cognitive health products and services.
As the health care sector evolves, Alpha Cognition Inc. remains poised to leverage its expertise and innovative solutions to meet the growing demand for cognitive health interventions. The company’s strategic focus and market positioning are critical factors that will likely influence its trajectory in the coming months.
